Literature DB >> 15709789

Cryptococcemia. An analysis of 28 cases with emphasis on the clinical outcome and its etiologic agent.

Alessandro Comarú Pasqualotto1, Cecília Bittencourt Severo, Flávio de Mattos Oliveira, Luiz Carlos Severo.   

Abstract

Clinical protocols of 28 cases of cryptococcemia studied between April 1995 and November 2002 were reviewed. The varieties of Cryptococcus neorformans, the underlying disease, and the severity and outcome of the disease were emphasized. Most patients were immunossupressed (89.3% with AIDS) and Cryptococcus neoformans var. grubii was the main recovered variety (92.8%). Regardless of antifungal treatment, in-hospital mortality was 41% strongly associated with APACHE II score, >14 (p<0.01).

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15709789

Source DB:  PubMed          Journal:  Rev Iberoam Micol        ISSN： 1130-1406            Impact factor:   1.044


  11 in total

1.  Challenges in dealing with a cirrhotic patient.

Authors:  Diana Spinelli; Sarah Damanti; Francesca Minonzio; Cinzia Hu; Maria Domenica Cappellini
Journal:  Intern Emerg Med       Date:  2012-03-15       Impact factor: 3.397

2.  Diagnosis and successful treatment of Cryptococcus neoformans variety grubii in a domestic ferret.

Authors:  Christopher S Hanley; Peter MacWilliams; Steve Giles; Jean Paré
Journal:  Can Vet J       Date:  2006-10       Impact factor: 1.008

3.  Disseminated cryptococcosis in HIV-uninfected patients.

Authors:  Y-M Chuang; Y-C Ho; H-T Chang; C-J Yu; P-C Yang; P-R Hsueh
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2008-04       Impact factor: 3.267

4.  First molecular typing of cryptococcemia-causing cryptococcus in central-west Brazil.

Authors:  Rosianne Assis de Sousa Tsujisaki; Anamaria Mello Miranda Paniago; Manoel Sebastião da Costa Lima Júnior; Débora de Souza Olartechea de Alencar; Fernanda Luíza Espinosa Spositto; Maína de Oliveira Nunes; Luciana Trilles; Marilene Rodrigues Chang
Journal:  Mycopathologia       Date:  2013-07-12       Impact factor: 2.574

5.  Role of quantitative CSF microscopy to predict culture status and outcome in HIV-associated cryptococcal meningitis in a Brazilian cohort.

Authors:  José E Vidal; Juliana Gerhardt; Erique J Peixoto de Miranda; Rafi F Dauar; Gilberto S Oliveira Filho; Augusto C Penalva de Oliveira; David R Boulware
Journal:  Diagn Microbiol Infect Dis       Date:  2012-05       Impact factor: 2.803

Review 6.  LATERAL FLOW ASSAY FOR CRYPTOCOCCAL ANTIGEN: AN IMPORTANT ADVANCE TO IMPROVE THE CONTINUUM OF HIV CARE AND REDUCE CRYPTOCOCCAL MENINGITIS-RELATED MORTALITY.

Authors:  Jose E Vidal; David R Boulware
Journal:  Rev Inst Med Trop Sao Paulo       Date:  2015-09       Impact factor: 1.846

7.  The clinical characteristics and therapeutic outcomes of cryptococcal meningitis in elderly patients: a hospital-based study.

Authors:  Wan-Chen Tsai; Chia-Yi Lien; Jun-Jun Lee; Wen-Chiu Hsiao; Chi-Ren Huang; Nai-Wen Tsai; Chiung-Chih Chang; Cheng-Hsien Lu; Wen-Neng Chang
Journal:  BMC Geriatr       Date:  2019-03-25       Impact factor: 3.921

8.  A case-control study of human immunodeficiency virus-negative patients with cryptococcemia and cryptococcal meningitis in a Chinese tertiary care hospital during 10 years.

Authors:  Liling Liang; Zhixin Liang; Danyang She; Liang'an Chen
Journal:  J Int Med Res       Date:  2021-01       Impact factor: 1.671

Review 9.  Strategies to reduce mortality and morbidity due to AIDS-related cryptococcal meningitis in Latin America.

Authors:  Jose E Vidal; Augusto C Penalva de Oliveira; Rafi F Dauar; David R Boulware
Journal:  Braz J Infect Dis       Date:  2013-05-10       Impact factor: 1.949

10.  Disseminated cryptococcosis with widespread necrotizing fasciitis and cryptococcemia occurring in an immunosuppressed patient.

Authors:  Feng Li; Hong-Ming Yang; Hong-Wei Wang
Journal:  Ann Dermatol       Date:  2014-04-30       Impact factor: 1.444
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.